CD8A and neoplasm: Recent studies have shown that the spatial localization of CD8+ T cells is predictive of TNBC clinical outcomes, in which CD8+ T-cell penetration into the tumor core (immune inflamed) correlated with proinflammatory immune response and predicted improved survival (13).